Table 1.
Baseline characteristics of the study population
| Number | 4518 |
| Age (years) | 43.5 ± 9.3 |
| Females (%) | 1279 (28.3%) |
| Blacks (%) | 1311 (29.0%) |
| Smoking (%) | |
| Current | 1799 (39.8%) |
| Ever | 2892 (64.0%) |
| Total cholesterol (mg/dL) | 195.7 ± 47.8 |
| LDL cholesterol (mg/dL) | 114.4 ± 35.3 |
| HDL cholesterol (mg/dL) | 43.3 ± 14.7 |
| Triglycerides (mg/dL) | 217.7 ± 217.6 |
| Total cholesterol/HDL | 5.0 ± 2.4 |
| Body mass index (kg/m2) | 25.9 ± 5.4 |
| Diabetes mellitus (%) | 287 (6.4%) |
| Blood pressure-lowering drugs (%) | 723 (16.0%) |
| Lipid lowering drugs (%) | 615 (13.6%) |
| Baseline CD4 count (cells/mm3) | 657.4 ± 255.4 |
| HIV RNA (% ≤ 400 copies/mL) | 3226 (71.6%) |
| Antiretroviral use at baseline (%) | |
| Antiretroviral naïve | 210 (4.6%) |
| No prior use of antiretroviral drugs, | 516 (11.4%) |
| Protease inhibitors | 1736 (38.4%) |
| Non-nucleoside Reverse Transcriptase Inhibitor | 1623 (35.9%) |
| Others | 433 (9.6%) |
Values are expressed as mean± SD or N (%)